Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Intravesical chemotherapy and immunotherapy for superficial tumors. Local targets link to admitted publications; unresolved targets remain external evidence.
Prognostic factors in superficial bladder cancer
1986 · External reference
Prognostic factors in Ta, T1 (superficial) bladder cancer
1993 · External reference
Intravesical chemotherapy and immunotherapy
10.1111/j.1442-2042.1995.tb00476.x · 1995 · External reference
Urothelial susceptibility to tumor cell implantation. Influence of cauterization
10.1002/1097-0142(19800901)46:5<1158::aid-cncr2820460514>3.0.co;2-e · 1980 · External reference
Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy
1976 · External reference
The etiology of bladder cancer. Are there any new clues or predictors of behavior?
10.1111/j.1442-2042.1995.tb00481.x · 1995 · External reference
Molecular epidemiology and retinoid chemoprevention of head and neck cancer
10.1093/jnci/89.3.199 · 1997 · External reference
Multistage carcinogenesis in the urinary bladder
10.1093/oxfordjournals.bmb.a071611 · 1980 · External reference
Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus
1994 · External reference
Clinical study on urothelial tumors of dye workers in Wakayama city
10.1016/s0022-5347(17)38151-x · 1991 · External reference
Present states and problems of intravesical instillation against superficial bladder cancer
1988 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Strategy for prevention of recurrence of superficial bladder cancer
10.1055/s-2008-1055634 · 1996 · External reference
Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumors
10.1046/j.1464-410x.1997.00142.x · 1997 · External reference
Bacillus calmette-guerin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder
10.1002/1097-0142(19950115)75:2<552::aid-cncr2820750219>3.0.co;2-h · 1995 · External reference
The national cancer data base report on bladder carcinoma
10.1002/(sici)1097-0142(19961001)78:7<1505::aid-cncr19>3.0.co;2-3 · 1996 · External reference
Factors affecting recurrence and progression in superficial bladder tumours
10.1016/0959-8049(95)00287-s · 1995 · External reference
Long term results of intravesical therapy for superficial bladder cancer
10.1016/s0094-0143(21)00424-9 · 1992 · External reference
A combined analysis of EORTC and MRC randomized clinical trials for the prophylactic treatment of stage Ta T1 bladder cancer
10.1016/s0022-5347(01)65396-5 · 1996 · External reference
Long-term results of intravesical chemoprophylaxis of superficial bladder cancer
10.1007/bf00686935 · 1992 · External reference
Bacillus calmette-guerin therapy for superficial bladder cancer
10.1016/s0022-5347(17)37452-9 · 1992 · External reference
Significant long-term patient benefit with BCG maintenance therapy
1997 · External reference
Members of EORTC Genitourinary Group. Phase II trials in Ta, T1 bladder cancer. The marker tumour concept
10.1046/j.1464-410x.1996.09002.x · 1996 · External reference
Chemoresection in Ta-T1 bladder cancer
10.1159/000473784 · 1996 · External reference
Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer
10.5980/jpnjurol1989.83.183 · 1992 · External reference
Bladder Cancer BCG Study Group. Bacillus calmette-guerin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder
10.1002/1097-0142(19950115)75:2<552::aid-cncr2820750219>3.0.co;2-h · 1995 · External reference
Effects of local BCG therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall
10.1016/s0022-5347(17)39365-5 · 1990 · External reference
Intravesical evans strain BCG therapy
10.1016/s0022-5347(17)37668-1 · 1992 · External reference
Neurophil-activating peptide-1/interleukin-8 detection in human urine during acute bladder inflammation caused by transurethral resection of superficial cancer and bacillus Calmette-Guérin administration
10.1159/000473608 · 1991 · External reference
Detection of urinary TNF, IL 1, and IL 2 after local BCG immunothrapy for bladder carcinoma
10.1016/1043-4666(90)90013-j · 1990 · External reference
Induction of urinary IL 1, IL2, IL6, and TNF during intravesical immunotherapy with BCG in superficial bladder cancer
10.1007/bf01741551 · 1991 · External reference
Urinary cytokines during intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer
10.1016/s0022-5347(01)66424-3 · 1996 · External reference
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy
10.1016/s0022-5347(17)39713-6 · 1990 · External reference
Interleukin 2 production during intravesical bacillus Calmette-Guérin therapy for bladder cancer
10.1016/0090-1229(86)90043-7 · 1986 · External reference
Long-term immunobiological effects of intravesical bacillus calmette-guerin against bladder carcinoma recurrences
1992 · External reference
Increase of HLA-AB and HLA-DR antigen expression on urothelial cells after BCG therapy
1993 · External reference
BCG immunotherapy induces ICAM-1 expression on bladder tumors
10.1136/jcp.47.4.309 · 1994 · External reference
Role of IL8 in onset of the BCG-induced immune response
10.1007/bf00941903 · 1997 · External reference
Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG)
10.1007/bf00296835 · 1993 · External reference
Double fluorescent flow cytometric assessment of bacterial internalization and binding by epithelial cells
10.1002/(sici)1097-0320(19961201)25:4<381::aid-cyto10>3.0.co;2-r · 1996 · External reference
Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro
10.1007/bf00184116 · 1994 · External reference
Morphological aspects of the interaction of bacillus Calmette-Guérin (BCG) with urological cells in vivo and in vitro
1992 · External reference
Expression of antitumor response
10.1002/1097-0142(19930715)72:2<558::aid-cncr2820720237>3.0.co;2-h · 1993 · External reference
Intravesical bacillus Calmette-Guérin therapy for murine bladder tumors
1987 · External reference
T-cell subsets required for intravesical BCG immunotherapy for bladder cancer
10.1016/s0022-5347(17)35678-1 · 1993 · External reference
Mechanisms of action of intravesical BCG for bladder cancer
1989 · External reference
Prognosis value of a Th1 urinary cytokine response following intravesical BCG treatment
1997 · External reference
Carcinoma in situ.
1992 · External reference
Urinary IL2 during repeated courses of intravesical BCG therapy
1996 · External reference
Mycobacterium cell wall
10.1016/s0022-5347(01)65748-3 · 1996 · External reference
Mycobacterial cell wall as an alternative to BCG in the treatment of carcinoma-in-situ (CIS) of bladder
1997 · External reference
Chemotactic activity of bacillus Calmette-Guérin (BCG) released product(s)
1996 · External reference
Culture filtrate from bacillus Calmette-Guérin (BCG) is as effective as live BCG to enhance lymphocyte-mediated bladder tumor cell killing in man and in mice
1997 · External reference
Oral bropirimine immunotherapy of carcinoma in situ of the bladder
10.1016/s0090-4295(96)90059-x · 1996 · External reference
Bropirimine (U-54461 S) late phase II clinical study for carcinoma in situ of the bladder
1997 · External reference
Bropirimine, early phase II clinical study in Ta, T1 bladder cancer
1996 · External reference
Randomized double-blind comparison of high and recommended dose vitamins in superficial bladder cancer
1993 · External reference
Influence of Lactobacillus casei on rat bladder carcinogenesis
10.5980/jpnjurol1989.85.655 · 1994 · External reference
Inhibitory effect of Lactobacillus casei on bladder carcinogenesis in mice
1993 · External reference
Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial
10.1159/000475138 · 1995 · External reference
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rat
10.1159/000474484 · 1997 · External reference
Induction of antitumor activity with oral administration
1992 · External reference
Effect of lactobacilli on urinary indican excretion in gnotobiotic rats and in men
10.1111/j.1348-0421.1981.tb00014.x · 1981 · External reference
Suppressing effect of Lactobacillus casei administration on the urinary mutogenecity arising from injestion of fried ground beef in the human
10.1016/0304-3835(93)90261-7 · 1993 · External reference
